CELL INTELLIGENCE · 肿瘤细胞治疗研究

CAR-T 与非 CAR-T 桥接策略在复发/难治性 B 细胞急性淋巴细胞白血病异基因造血干细胞移植前的比较：一项系统综述

CAR-T Versus Non-CAR-T Bridging Strategies Before Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Acute Lymphoblastic

一项研究报告，CAR-T 桥接后的累积复发率（CIR）显著更低，无病生存期（DFS）更高（18.9% vs.

多模式 C9-66 CAR-T 细胞免疫疗法改善胰腺癌临床前模型的结局

Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer.

C9-66 CAR-T 细胞经代谢优化与 TME 重编程，代表一种肿瘤特异性、可临床转化的免疫治疗策略，适用于 PDAC 及其他表达 ofCS 的实体瘤。

CAR-T 治疗与自体造血干细胞移植后的长期认知功能障碍：倾向性评分匹配队列研究

Long-Term Cognitive Impairment After CAR-T Therapy Versus Autologous Stem Cell Transplantation: A Propensity Score-Matched Cohort Study.

肿瘤微环境在介导放射性药物治疗中的作用：连接核医学与肿瘤免疫治疗

The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy.

基于 IL-15 的肿瘤免疫治疗进展及 IL-2 与 IL-15 通过共享 IL-2Rβγ 受体信号传导的不同免疫效应

Advances in IL-15-Based Cancer Immunotherapy and Divergent Immunological Effects of IL-2 and IL-15 Signaling via the Shared IL-2Rβγ Receptor.

FNDC4 驱动胰腺癌的转移和免疫逃逸

FNDC4 Drives Metastasis and Immune Evasion in Pancreatic Cancer.

过去十年肿瘤中 CAR-T 细胞耗竭：线粒体代谢作为对抗靶点

CAR-T Cell Exhaustion in Cancer over the Past Decade: Mitochondrial Metabolism as a Target for Counteraction.

改造肿瘤微环境：溶瘤 NDV 促进 CAR-T 细胞治疗

Engineering the tumor microenvironment: oncolytic NDV to facilitate CAR-T cell therapy.

基于 NK 细胞的髓系白血病免疫治疗策略

NK cell-based immunotherapy strategies for myeloid leukemia.

重编程乳腺肿瘤免疫微环境：冷转热以增强免疫治疗

Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.